IDEF: Expanding AD Options for Adults and Pediatric Patients 12 Years of Age and Older With Moderate

Please join us for our next IDEF Educational Series Webinar: Expanding AD Options for Adults and Pediatric Patients 12 Years of Age and Older With Moderate-to-Severe Atopic Dermatitis.

Join us for a Pfizer-sponsored presentation of CIBINQO, a once-daily, oral JAK inhibitor for the treatment of adults and pediatric patients 12 years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable.

------------------------------------------------------

Moderator:

Leon Kircik, MD, FAAD
President, International Dermatology Education Foundation
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York, NY
Indiana University Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY
Skin Sciences, PLLC, Louisville, KY


Speaker:

Peter Lio, MD
Medical Dermatology Associates of Chicago
Chicago, IL
Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Founding Director of the Chicago Integrative Eczema Center
Founding Partner of Medical Dermatology Associates of Chicago